Triple-Negative Breast Cancers do not express the receptors that act as common targets for treatment, so are of special interest. These samples can be sub-grouped within a SampleSet, and this SampleSet grouping can be used to compare samples for differences in expression, mutation frequency, clinical variables, etc.